GlassScriptPhysician profile
Cornelia C Abanobi
NPI 1831889005
$2,801.84
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $209 · 2024: $2,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,151.96 |
| Travel and Lodging | $649.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,619.34 | 2023-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Kiniksa Pharmaceuticals International, Plc | $172.89 | 2024 | Arcalyst |
| Abbott Laboratories | $136.33 | 2024 | Xact |
| Actelion Pharmaceuticals US, INC. | $118.51 | 2023-2024 | Uptravi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $118.00 | 2024 | Inpefa |
| Inspire Medical Systems, INC. | $94.69 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.54 | 2024 | Jardiance |
| Amgen INC. | $88.51 | 2023-2024 | Repatha |
| Baxter Healthcare | $58.01 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $54.14 | 2023-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $43.17 | 2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $39.30 | 2024 | Optimizer |
| Heartflow, INC. | $30.66 | 2024 | |
| Abiomed | $30.51 | 2024 | Impella |
| Medtronic, INC. | $26.33 | 2024 | Cobalt Dr Mri Surescan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.68 | 2024 | |
| Irhythm Technologies, INC. | $20.77 | 2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $17.86 | 2024 | Kengreal |
| Novartis Pharmaceuticals Corporation | $15.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornelia Abanobi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.